HEADER COMPLEX (BLOOD COAGULATION/PEPTIDE) 03-JUN-97 2FIB TITLE RECOMBINANT HUMAN GAMMA-FIBRINOGEN CARBOXYL TERMINAL FRAGMENT TITLE 2 (RESIDUES 143-411) COMPLEXED TO THE PEPTIDE GLY-PRO-ARG-PRO AT PH 6.0 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBRINOGEN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: GAMMA CHAIN, CARBOXYL TERMINAL FRAGMENT RESIDUES 143 - 411; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: GLY-PRO-ARG-PRO; COMPND 8 CHAIN: B; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: BLOOD; SOURCE 6 TISSUE: BLOOD PLASMA; SOURCE 7 GENE: HUMAN FIBRINOGEN GAMMA CHAIN CDNA ENCODING VAL 143 - VAL 411; SOURCE 8 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPIC9K; SOURCE 11 MOL_ID: 2 KEYWDS FIBRINOGEN, BLOOD COAGULATION, FIBRIN POLYMERIZATION, COMPLEX (BLOOD KEYWDS 2 COAGULATION-PEPTIDE), COMPLEX (BLOOD COAGULATION-PEPTIDE) COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.P.PRATT,H.C.F.COTE,D.W.CHUNG,R.E.STENKAMP,E.W.DAVIE REVDAT 3 09-AUG-23 2FIB 1 REMARK LINK REVDAT 2 24-FEB-09 2FIB 1 VERSN REVDAT 1 15-OCT-97 2FIB 0 JRNL AUTH K.P.PRATT,H.C.COTE,D.W.CHUNG,R.E.STENKAMP,E.W.DAVIE JRNL TITL THE PRIMARY FIBRIN POLYMERIZATION POCKET: THREE-DIMENSIONAL JRNL TITL 2 STRUCTURE OF A 30-KDA C-TERMINAL GAMMA CHAIN FRAGMENT JRNL TITL 3 COMPLEXED WITH THE PEPTIDE GLY-PRO-ARG-PRO. JRNL REF PROC.NATL.ACAD.SCI.USA V. 94 7176 1997 JRNL REFN ISSN 0027-8424 JRNL PMID 9207064 JRNL DOI 10.1073/PNAS.94.14.7176 REMARK 2 REMARK 2 RESOLUTION. 2.01 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.01 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 3.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 12275 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1205 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 10.00 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 380 REMARK 3 BIN R VALUE (WORKING SET) : 0.2542 REMARK 3 BIN FREE R VALUE : 0.3957 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 39 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2033 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 1 REMARK 3 SOLVENT ATOMS : 115 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.903 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.43 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.130 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARAM.CALCIUM REMARK 3 PARAMETER FILE 2 : PARAM.TIPS3P REMARK 3 PARAMETER FILE 3 : PARAMCISPEP.PRO REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPCISPEP.PRO REMARK 3 TOPOLOGY FILE 2 : TOPOLOGY.CALCIUM REMARK 3 TOPOLOGY FILE 3 : TOPOLOGY.TIPS3P REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 MODIFIED TOPOLOGY AND PARAMETER FILES WERE CREATED SO THAT X-PLOR REMARK 3 WOULD ACCEPT A CIS PEPTIDE BOND THAT DID NOT PRECEDE A PROLINE REMARK 3 RESIDUE. THE PDB INPUT FILE FOR X-PLOR SHOULD SPECIFY CYS 339 AS REMARK 3 CCY 339. REMARK 3 REMARK 3 THE BACKBONE ANGLES PHI AND PSI OF ASN 337 ARE STRAINED. REMARK 4 REMARK 4 2FIB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000178092. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : SEP-95 REMARK 200 TEMPERATURE (KELVIN) : 300 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : RIGAKU SOFTWARE REMARK 200 DATA SCALING SOFTWARE : RIGAKU REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12275 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 68.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 76.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : 0.05200 REMARK 200 FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.01 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.25 REMARK 200 COMPLETENESS FOR SHELL (%) : 61.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.170 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: ISOMORPHOUS WITH PDB ENTRY REMARK 200 1FIB REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: PDB ENTRY 1FIB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.91 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM 12% REMARK 280 PEG8000, 70MM CACL2, 0.1 M MES, PH 6.0, 0.02%NAN3, ROOM REMARK 280 TEMPERATURE, SITTING DROPS. THE CRYSTAL WAS SOAKED OVERNIGHT IN REMARK 280 THE ORIGINAL SOLUTION PLUS 0.01M GLY-PRO-ARG-PRO (SIGMA), THEN REMARK 280 BACK-SOAKED FOR 10 MINUTES., VAPOR DIFFUSION - SITTING DROP, REMARK 280 VAPOR DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.10000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10460 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 393 REMARK 465 ILE A 394 REMARK 465 GLY A 395 REMARK 465 GLU A 396 REMARK 465 GLY A 397 REMARK 465 GLN A 398 REMARK 465 GLN A 399 REMARK 465 HIS A 400 REMARK 465 HIS A 401 REMARK 465 LEU A 402 REMARK 465 GLY A 403 REMARK 465 GLY A 404 REMARK 465 ALA A 405 REMARK 465 LYS A 406 REMARK 465 GLN A 407 REMARK 465 ALA A 408 REMARK 465 GLY A 409 REMARK 465 ASP A 410 REMARK 465 VAL A 411 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 144 80.26 -167.07 REMARK 500 LEU A 198 -18.44 -157.00 REMARK 500 ASP A 199 -1.40 -152.07 REMARK 500 ASP A 288 79.29 -101.99 REMARK 500 ASN A 317 79.49 -164.82 REMARK 500 ASN A 337 -97.35 -112.52 REMARK 500 LYS A 338 63.21 -157.46 REMARK 500 SER A 358 -5.27 -56.60 REMARK 500 PRO A 360 -37.62 -38.92 REMARK 500 ASN A 361 34.39 -98.91 REMARK 500 PRO B 3 -168.90 -79.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 412 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 318 OD2 REMARK 620 2 ASP A 318 OD1 46.1 REMARK 620 3 ASP A 320 OD1 103.1 62.3 REMARK 620 4 PHE A 322 O 161.0 137.9 75.7 REMARK 620 5 GLY A 324 O 81.2 109.1 101.6 80.5 REMARK 620 6 HOH A 413 O 108.1 75.4 71.3 89.6 169.1 REMARK 620 7 HOH A 414 O 81.0 110.7 158.0 107.4 100.4 86.9 REMARK 620 N 1 2 3 4 5 6 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 412 REMARK 999 REMARK 999 SEQUENCE REMARK 999 NO DENSITY FOR RESIDUES BEYOND LEU 392 WAS OBSERVED. REMARK 999 MASS SPECTROMETRY SHOWED HETEROGENEITY AT THE C-TERMINUS. DBREF 2FIB A 143 411 UNP P02679 FIBG_HUMAN 169 437 DBREF 2FIB B 2 5 PDB 2FIB 2FIB 2 5 SEQRES 1 A 269 VAL GLN ILE HIS ASP ILE THR GLY LYS ASP CYS GLN ASP SEQRES 2 A 269 ILE ALA ASN LYS GLY ALA LYS GLN SER GLY LEU TYR PHE SEQRES 3 A 269 ILE LYS PRO LEU LYS ALA ASN GLN GLN PHE LEU VAL TYR SEQRES 4 A 269 CYS GLU ILE ASP GLY SER GLY ASN GLY TRP THR VAL PHE SEQRES 5 A 269 GLN LYS ARG LEU ASP GLY SER VAL ASP PHE LYS LYS ASN SEQRES 6 A 269 TRP ILE GLN TYR LYS GLU GLY PHE GLY HIS LEU SER PRO SEQRES 7 A 269 THR GLY THR THR GLU PHE TRP LEU GLY ASN GLU LYS ILE SEQRES 8 A 269 HIS LEU ILE SER THR GLN SER ALA ILE PRO TYR ALA LEU SEQRES 9 A 269 ARG VAL GLU LEU GLU ASP TRP ASN GLY ARG THR SER THR SEQRES 10 A 269 ALA ASP TYR ALA MET PHE LYS VAL GLY PRO GLU ALA ASP SEQRES 11 A 269 LYS TYR ARG LEU THR TYR ALA TYR PHE ALA GLY GLY ASP SEQRES 12 A 269 ALA GLY ASP ALA PHE ASP GLY PHE ASP PHE GLY ASP ASP SEQRES 13 A 269 PRO SER ASP LYS PHE PHE THR SER HIS ASN GLY MET GLN SEQRES 14 A 269 PHE SER THR TRP ASP ASN ASP ASN ASP LYS PHE GLU GLY SEQRES 15 A 269 ASN CYS ALA GLU GLN ASP GLY SER GLY TRP TRP MET ASN SEQRES 16 A 269 LYS CYS HIS ALA GLY HIS LEU ASN GLY VAL TYR TYR GLN SEQRES 17 A 269 GLY GLY THR TYR SER LYS ALA SER THR PRO ASN GLY TYR SEQRES 18 A 269 ASP ASN GLY ILE ILE TRP ALA THR TRP LYS THR ARG TRP SEQRES 19 A 269 TYR SER MET LYS LYS THR THR MET LYS ILE ILE PRO PHE SEQRES 20 A 269 ASN ARG LEU THR ILE GLY GLU GLY GLN GLN HIS HIS LEU SEQRES 21 A 269 GLY GLY ALA LYS GLN ALA GLY ASP VAL SEQRES 1 B 4 GLY PRO ARG PRO HET CA A 412 1 HETNAM CA CALCIUM ION FORMUL 3 CA CA 2+ FORMUL 4 HOH *115(H2 O) HELIX 1 1 CYS A 153 ASN A 158 1 6 HELIX 2 2 TRP A 208 GLU A 213 1 6 HELIX 3 3 ASN A 230 SER A 237 1 8 HELIX 4 4 GLN A 239 ALA A 241 5 3 HELIX 5 5 GLU A 270 ASP A 272 5 3 HELIX 6 6 ALA A 289 ASP A 291 5 3 HELIX 7 7 ASP A 301 THR A 305 1 5 HELIX 8 8 CYS A 326 ASP A 330 1 5 HELIX 9 9 LYS A 356 SER A 358 5 3 HELIX 10 10 PHE A 389 ARG A 391 5 3 SHEET 1 A 8 TYR A 280 GLY A 283 0 SHEET 2 A 8 THR A 257 ALA A 263 -1 N ALA A 263 O TYR A 280 SHEET 3 A 8 TYR A 244 GLU A 251 -1 N LEU A 250 O SER A 258 SHEET 4 A 8 LYS A 381 PRO A 388 -1 N ILE A 387 O ALA A 245 SHEET 5 A 8 GLY A 190 ARG A 197 -1 N ARG A 197 O THR A 382 SHEET 6 A 8 PHE A 178 ILE A 184 -1 N GLU A 183 O TRP A 191 SHEET 7 A 8 GLY A 165 ILE A 169 -1 N ILE A 169 O PHE A 178 SHEET 8 A 8 ILE A 145 GLY A 150 1 N HIS A 146 O LEU A 166 SSBOND 1 CYS A 153 CYS A 182 1555 1555 2.03 SSBOND 2 CYS A 326 CYS A 339 1555 1555 2.02 LINK OD2 ASP A 318 CA CA A 412 1555 1555 2.40 LINK OD1 ASP A 318 CA CA A 412 1555 1555 2.96 LINK OD1 ASP A 320 CA CA A 412 1555 1555 2.42 LINK O PHE A 322 CA CA A 412 1555 1555 2.20 LINK O GLY A 324 CA CA A 412 1555 1555 2.33 LINK CA CA A 412 O HOH A 413 1555 1555 2.54 LINK CA CA A 412 O HOH A 414 1555 1555 2.47 CISPEP 1 LYS A 338 CYS A 339 0 -0.53 SITE 1 AC1 6 ASP A 318 ASP A 320 PHE A 322 GLY A 324 SITE 2 AC1 6 HOH A 413 HOH A 414 CRYST1 37.330 68.200 47.600 90.00 105.02 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026788 0.000000 0.007188 0.00000 SCALE2 0.000000 0.014663 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021752 0.00000